Bio-Path Holdings, Inc.
BPTH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | -0.00 | 0.01 |
| FCF Yield | -20.04% | -109,367.45% | -103.44% | -124.86% |
| EV / EBITDA | -0.42 | -0.07 | -0.66 | -0.85 |
| Quality | ||||
| ROIC | 68.72% | 145.08% | -390.68% | 685.94% |
| Gross Margin | 0.00% | 0.00% | 50.00% | 0.00% |
| Cash Conversion Ratio | 0.06 | 0.46 | 1.05 | 1.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 540,512.02% | 540,512.02% | 540,512.02% | 649,406.53% |
| Free Cash Flow Growth | 78.45% | 54.43% | 15.96% | -6.20% |
| Safety | ||||
| Net Debt / EBITDA | -0.11 | -0.07 | 0.42 | 0.21 |
| Interest Coverage | -130.34 | -648.20 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.06 |
| Cash Conversion Cycle | -7,636.83 | -6,856.88 | 0.00 | -1,377.27 |